Kallikrein 9 Antibody (N-term) Blocking peptide
€363.00
In stock
SKU
AC-BP6328a
Background:
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK9 is a novel kallikrein with poptential application for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.
Other Names:
Kallikrein-9, 3421-, Kallikrein-like protein 3, KLK-L3, KLK9
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6328a was selected from the N-term region of human KLK9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KLK9
Gene ID: 284366
Primary Accession: Q9UKQ9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK9 is a novel kallikrein with poptential application for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.
Other Names:
Kallikrein-9, 3421-, Kallikrein-like protein 3, KLK-L3, KLK9
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6328a was selected from the N-term region of human KLK9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KLK9
Gene ID: 284366
Primary Accession: Q9UKQ9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review